Year: 2026
Project CBD Newsletter: Cannabis Rescheduling and Criminal Penalties, Trump’s Psychedelics Executive Order, THC Potency Mislabeling, Psilocybin for OCD, and CBD’s Potential Against Alzheimer’s
This week’s newsletter covers the limits of cannabis rescheduling on federal criminal penalties, the largely symbolic nature of Trump’s psychedelics executive order, concerns about inflated THC potency on product labels, promising psilocybin research for OCD, […]
Plain Jane CBD Moonrock strain review
Check on YouTube
Project CBD Newsletter: Trump’s Cannabis Rescheduling Reality, CBD for Wound Healing and Rheumatoid Arthritis, Medical Cannabis for Migraines, and Rare Cannabis Compounds
This week’s newsletter covers the limited scope of Trump’s cannabis rescheduling announcement, new research on CBD’s potential in wound healing and rheumatoid arthritis, a longitudinal study on medical cannabis for migraine patients, and the discovery […]
Project CBD Newsletter: Federally-Funded Study Links Cannabis Access to Opioid Overdose Reduction, CBD-Based Plastics, Psychedelic Risks, Runner’s High Neurochemistry, CBG for Arthritis, Terpenes for Diabetes and Cancer, and Cannabinoids for Fibromyalgia
This week’s newsletter covers a federally funded study on cannabis access and opioid overdose reduction, the potential of CBD-derived plastics, the risks of psychedelic therapy, the endocannabinoid system’s role in the runner’s high, and new […]
Project CBD Newsletter: CBD Bioavailability and Delivery Methods, Psychedelic Trial Safety Concerns, Endocannabinoid System Research, and Ibogaine’s Effects on Veterans
This week’s newsletter covers an Iranian study on CBD bioavailability and delivery methods, critiques of Canada’s cannabis market and flavored vape policy, therapist concerns around psychedelic trials, and new research on the endocannabinoid system’s connections […]
Your Body ● After Smoking Cannabis for a Month
Check on YouTube